Acurx Pharmaceuticals Ownership 2024 | Who Owns Acurx Pharmaceuticals Now?

OverviewFinancials Chart Transcripts

Institutional Ownership

7.78%

Insider Ownership

14.80%

Retail Ownership

77.41%

Institutional Holders

25.00

Acurx Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	3.18%	-	491,687	-	-	1,106,296	Jun 30, 2024
PROSPECT FINANCIAL SERVICES LLC	1.80%	0.48%	278,100	5,250	1.92%	625,725	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.84%	-	130,015	13,663	11.74%	292,574	Jun 30, 2024
LPL FINANCIAL LLC	0.35%	0.00%	53,735	13,500	33.55%	120,904	Jun 30, 2024
MORGAN STANLEY	0.30%	-	46,401	20,000	75.75%	104,402	Jun 30, 2024
STATE STREET CORP	0.28%	-	43,466	-	-	97,799,000	Jun 30, 2024
BLACKROCK INC.	0.18%	-	27,503	8,815	47.17%	61,882	Jun 30, 2024
NORTHERN TRUST CORP	0.18%	-	27,286	10,133	59.07%	61,394,000	Jun 30, 2024
NBC SECURITIES, INC.	0.12%	0.00%	19,000	5,000	35.71%	42,000	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.12%	0.00%	18,656	-	-	49,275	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.10%	0.00%	15,210	-42,040	-73.43%	34,222	Jun 30, 2024
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC	0.07%	0.00%	10,385	-	-	23,366	Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.06%	0.00%	10,000	-	-	23,000	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.06%	0.00%	10,000	-	-	22,500	Jun 30, 2024
SEMMAX FINANCIAL ADVISORS INC.	0.04%	0.00%	5,879	-	-	11,170	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.03%	-	5,222	-8,259	-61.26%	11,750,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	4,138	1,270	44.28%	9,310	Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC	0.02%	0.00%	3,344	-	-	6,488	Jun 30, 2024
SIMPLEX TRADING, LLC	0.02%	-	2,918	-7,811	-72.80%	6,000	Jun 30, 2024
UBS GROUP AG	0.01%	-	881	881	100.00%	1,982	Jun 30, 2024

Acurx Pharmaceuticals's largest institutional shareholder is VANGUARD GROUP INC, holding 3.18% of the company's total share outstanding, currently valued at $1.11M. The top 10 institutional shareholders own together 7.34% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PROSPECT FINANCIAL SERVICES LLC	1.80%	0.48%	278,100	5,250	1.92%	625,725	Jun 30, 2024
NBC SECURITIES, INC.	0.12%	0.00%	19,000	5,000	35.71%	42,000	Jun 30, 2024
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC	0.07%	0.00%	10,385	-	-	23,366	Jun 30, 2024
SEMMAX FINANCIAL ADVISORS INC.	0.04%	0.00%	5,879	-	-	11,170	Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC	0.02%	0.00%	3,344	-	-	6,488	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.06%	0.00%	10,000	-	-	22,500	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.12%	0.00%	18,656	-	-	49,275	Jun 30, 2024
GPS WEALTH STRATEGIES GROUP, LLC	0.00%	0.00%	500	-	-	1,125	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	4,138	1,270	44.28%	9,310	Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.06%	0.00%	10,000	-	-	23,000	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.10%	0.00%	15,210	-42,040	-73.43%	34,222	Jun 30, 2024
LPL FINANCIAL LLC	0.35%	0.00%	53,735	13,500	33.55%	120,904	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.03%	-	5,222	-8,259	-61.26%	11,750,000	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.84%	-	130,015	13,663	11.74%	292,574	Jun 30, 2024
VANGUARD GROUP INC	3.18%	-	491,687	-	-	1,106,296	Jun 30, 2024
NORTHERN TRUST CORP	0.18%	-	27,286	10,133	59.07%	61,394,000	Jun 30, 2024
MORGAN STANLEY	0.30%	-	46,401	20,000	75.75%	104,402	Jun 30, 2024
STATE STREET CORP	0.28%	-	43,466	-	-	97,799,000	Jun 30, 2024
SIMPLEX TRADING, LLC	0.02%	-	2,918	-7,811	-72.80%	6,000	Jun 30, 2024
BLACKROCK INC.	0.18%	-	27,503	8,815	47.17%	61,882	Jun 30, 2024

The largest Acurx Pharmaceuticals shareholder by % of total assets is PROSPECT FINANCIAL SERVICES LLC. The company owns 278.10K shares of Acurx Pharmaceuticals (ACXP), representing 0.48% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.30%	-	46,401	20,000	75.75%	104,402	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.84%	-	130,015	13,663	11.74%	292,574	Jun 30, 2024
LPL FINANCIAL LLC	0.35%	0.00%	53,735	13,500	33.55%	120,904	Jun 30, 2024
NORTHERN TRUST CORP	0.18%	-	27,286	10,133	59.07%	61,394,000	Jun 30, 2024
BLACKROCK INC.	0.18%	-	27,503	8,815	47.17%	61,882	Jun 30, 2024
PROSPECT FINANCIAL SERVICES LLC	1.80%	0.48%	278,100	5,250	1.92%	625,725	Jun 30, 2024
NBC SECURITIES, INC.	0.12%	0.00%	19,000	5,000	35.71%	42,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	4,138	1,270	44.28%	9,310	Jun 30, 2024
UBS GROUP AG	0.01%	-	881	881	100.00%	1,982	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	105	105	100.00%	236	Jun 30, 2024
STATE STREET CORP	0.28%	-	43,466	-	-	97,799,000	Jun 30, 2024
VANGUARD GROUP INC	3.18%	-	491,687	-	-	1,106,296	Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.06%	0.00%	10,000	-	-	23,000	Jun 30, 2024
GPS WEALTH STRATEGIES GROUP, LLC	0.00%	0.00%	500	-	-	1,125	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.12%	0.00%	18,656	-	-	49,275	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.06%	0.00%	10,000	-	-	22,500	Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC	0.02%	0.00%	3,344	-	-	6,488	Jun 30, 2024
SEMMAX FINANCIAL ADVISORS INC.	0.04%	0.00%	5,879	-	-	11,170	Jun 30, 2024
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC	0.07%	0.00%	10,385	-	-	23,366	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-87	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Acurx Pharmaceuticals's largest institutional buyer is MORGAN STANLEY. The company purchased 20.00K stocks of ACXP, valued at $104.40K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISOR GROUP HOLDINGS, INC.	0.10%	0.00%	15,210	-42,040	-73.43%	34,222	Jun 30, 2024
XTX TOPCO LTD	-	-	-	-13,041	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-12,986	-100.00%	-	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.03%	-	5,222	-8,259	-61.26%	11,750,000	Jun 30, 2024
SIMPLEX TRADING, LLC	0.02%	-	2,918	-7,811	-72.80%	6,000	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-87	-100.00%	-	Jun 30, 2024
PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC	0.07%	0.00%	10,385	-	-	23,366	Jun 30, 2024
SEMMAX FINANCIAL ADVISORS INC.	0.04%	0.00%	5,879	-	-	11,170	Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC	0.02%	0.00%	3,344	-	-	6,488	Jun 30, 2024
TOCQUEVILLE ASSET MANAGEMENT L.P.	0.06%	0.00%	10,000	-	-	22,500	Jun 30, 2024
TD WATERHOUSE CANADA INC.	0.12%	0.00%	18,656	-	-	49,275	Jun 30, 2024
GPS WEALTH STRATEGIES GROUP, LLC	0.00%	0.00%	500	-	-	1,125	Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.06%	0.00%	10,000	-	-	23,000	Jun 30, 2024
VANGUARD GROUP INC	3.18%	-	491,687	-	-	1,106,296	Jun 30, 2024
STATE STREET CORP	0.28%	-	43,466	-	-	97,799,000	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	105	105	100.00%	236	Jun 30, 2024
UBS GROUP AG	0.01%	-	881	881	100.00%	1,982	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.03%	0.00%	4,138	1,270	44.28%	9,310	Jun 30, 2024
NBC SECURITIES, INC.	0.12%	0.00%	19,000	5,000	35.71%	42,000	Jun 30, 2024
PROSPECT FINANCIAL SERVICES LLC	1.80%	0.48%	278,100	5,250	1.92%	625,725	Jun 30, 2024

As of Jun 30 2024, Acurx Pharmaceuticals's biggest institutional seller is ADVISOR GROUP HOLDINGS, INC.. The company sold -42.04K shares of ACXP, valued at $34.22K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.01%	-	881	881	100.00%	1,982	Jun 30, 2024

Acurx Pharmaceuticals's largest new institutional shareholder by number of shares is UBS GROUP AG, purchased 881.00 shares, valued at $1.98K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
XTX TOPCO LTD	-	-	-	-13,041	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-12,986	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-87	-100.00%	-	Jun 30, 2024

Acurx Pharmaceuticals's largest sold out institutional shareholder by shares sold is XTX TOPCO LTD, sold -13.04K shares, valued at -, as of undefined.

Acurx Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	491,687	-60,237	-10.91%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	106,517	-5,716	-5.09%	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,158	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	3,065	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	1,250	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	16,234	-428	-2.57%	Mar 31, 2024
Dimensional ETF Trust	0.00%	200	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	299	-	-	Mar 31, 2024

Acurx Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 491.69K shares, compromising 0.00% of its total assets.

Acurx Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	25	-7.41%
31 Mar, 24	27	8.00%
31 Dec, 23	25	47.06%
30 Sep, 23	17	41.67%
30 Jun, 23	12	-
31 Mar, 23	12	-14.29%
31 Dec, 22	14	16.67%
30 Sep, 22	12	9.09%
30 Jun, 22	11	37.50%
31 Mar, 22	8	-
31 Dec, 21	8	14.29%
30 Sep, 21	7	133.33%
30 Jun, 21	3	-

As of 30 Jun 24, 25 institutions are holding Acurx Pharmaceuticals's shares, representing a decrease of -7.41% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	1,204,495	-3.54%
31 Mar, 24	1,248,676	14.30%
31 Dec, 23	1,092,462	24.40%
30 Sep, 23	878,194	-40.86%
30 Jun, 23	1,484,920	175.70%
31 Mar, 23	538,592	-59.30%
31 Dec, 22	1,323,380	-14.74%
30 Sep, 22	1,552,171	312.74%
30 Jun, 22	376,069	8.04%
31 Mar, 22	348,097	236.76%
31 Dec, 21	103,366	59.82%
30 Sep, 21	64,675	154.01%
30 Jun, 21	25,462	-

Acurx Pharmaceuticals (ACXP) has 1.20M shares outstanding as of 30 Jun 24, down -3.54% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	7.78%	8.02%
31 Mar, 24	9.85%	13.97%
31 Dec, 23	8.40%	16.18%
30 Sep, 23	7.21%	4.43%
30 Jun, 23	12.76%	59.58%
31 Mar, 23	4.63%	1.93%
31 Dec, 22	15.50%	8.00%
30 Sep, 22	13.92%	103.70%
30 Jun, 22	3.66%	31.67%
31 Mar, 22	3.40%	231.97%
31 Dec, 21	1.21%	296.29%
30 Sep, 21	0.64%	478.82%
30 Jun, 21	0.37%	-

As of 30 Jun 24, Acurx Pharmaceuticals is held by 7.78% institutional shareholders, representing a 8.02% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	10	-41.18%
31 Mar, 24	17	-10.53%
31 Dec, 23	19	58.33%
30 Sep, 23	12	50.00%
30 Jun, 23	8	60.00%
31 Mar, 23	5	-
31 Dec, 22	5	-28.57%
30 Sep, 22	7	40.00%
30 Jun, 22	5	-
31 Mar, 22	5	-16.67%
31 Dec, 21	6	-14.29%
30 Sep, 21	7	133.33%
30 Jun, 21	3	-

10 institutional shareholders have increased their position in ACXP stock as of 30 Jun 24 compared to 17 in the previous quarter (a -41.18% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	4	33.33%
31 Mar, 24	3	200.00%
31 Dec, 23	1	-66.67%
30 Sep, 23	3	200.00%
30 Jun, 23	1	-66.67%
31 Mar, 23	3	-40.00%
31 Dec, 22	5	400.00%
30 Sep, 22	1	-50.00%
30 Jun, 22	2	100.00%
31 Mar, 22	1	-
31 Dec, 21	1	-
30 Sep, 21	-	-
30 Jun, 21	-	-

4 institutional shareholders have reduced their position in ACXP stock as of 30 Jun 24 compared to 3 in the previous quarter (a 33.33% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	25	-7.41%	1,204,495	-3.54%	7.78%	8.02%	10	-41.18%	4	33.33%
31 Mar, 24	27	8.00%	1,248,676	14.30%	9.85%	13.97%	17	-10.53%	3	200.00%
31 Dec, 23	25	47.06%	1,092,462	24.40%	8.40%	16.18%	19	58.33%	1	-66.67%
30 Sep, 23	17	41.67%	878,194	-40.86%	7.21%	4.43%	12	50.00%	3	200.00%
30 Jun, 23	12	-	1,484,920	175.70%	12.76%	59.58%	8	60.00%	1	-66.67%
31 Mar, 23	12	-14.29%	538,592	-59.30%	4.63%	1.93%	5	-	3	-40.00%
31 Dec, 22	14	16.67%	1,323,380	-14.74%	15.50%	8.00%	5	-28.57%	5	400.00%
30 Sep, 22	12	9.09%	1,552,171	312.74%	13.92%	103.70%	7	40.00%	1	-50.00%
30 Jun, 22	11	37.50%	376,069	8.04%	3.66%	31.67%	5	-	2	100.00%
31 Mar, 22	8	-	348,097	236.76%	3.40%	231.97%	5	-16.67%	1	-
31 Dec, 21	8	14.29%	103,366	59.82%	1.21%	296.29%	6	-14.29%	1	-
30 Sep, 21	7	133.33%	64,675	154.01%	0.64%	478.82%	7	133.33%	-	-
30 Jun, 21	3	-	25,462	-	0.37%	-	3	-	-	-

Acurx Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 22, 2024	Sailer Carl	director	-	M-Exempt	Sell	19,737	$3.55	$70.07K	-
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		G-Gift	Sell	40,000	-	-	1,011,198
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		G-Gift	Sell	40,000	-	-	971,198
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		G-Gift	Sell	30,000	-	-	941,198
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		M-Exempt	Sell	19,737	$3.55	$70.07K	-
Jan 04, 2024	LUCI DAVID P	director, 10 percent owner, officer	President and CEO	M-Exempt	Sell	19,737	$3.55	$70.07K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 18, 2024	Scodari Joseph C	director	-	A-Award	Buy	12,000	$2.38	$28.56K	12,000
Jun 18, 2024	Sailer Carl	director	-	A-Award	Buy	12,000	$2.38	$28.56K	12,000
Jun 18, 2024	HARRISON THOMAS L	director	-	A-Award	Buy	12,000	$2.38	$28.56K	12,000
Jun 18, 2024	Donohue James J.	director	-	A-Award	Buy	12,000	$2.38	$28.56K	12,000
Jun 18, 2024	DEAN JACK H	director	-	A-Award	Buy	12,000	$2.38	$28.56K	12,000
Apr 03, 2024	LUCI DAVID P	director, 10 percent owner, officer	President and CEO	A-Award	Buy	250,000	$3.15	$787.50K	250,000
Apr 03, 2024	Shawah Robert G.	officer	Chief Financial Officer	A-Award	Buy	145,000	$3.15	$456.75K	145,000
Apr 03, 2024	DELUCCIA ROBERT J	director, 10 percent owner		A-Award	Buy	250,000	$3.15	$787.50K	250,000
Jan 22, 2024	Sailer Carl	director	-	M-Exempt	Buy	19,737	$3.55	$70.07K	112,552
Jan 22, 2024	Sailer Carl	director	-	M-Exempt	Sell	19,737	$3.55	$70.07K	-
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		G-Gift	Sell	40,000	-	-	1,011,198
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		G-Gift	Sell	40,000	-	-	971,198
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		M-Exempt	Buy	19,737	$3.55	$70.07K	960,935
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		G-Gift	Sell	30,000	-	-	941,198
Jan 04, 2024	DELUCCIA ROBERT J	director, 10 percent owner		M-Exempt	Sell	19,737	$3.55	$70.07K	-
Jan 04, 2024	LUCI DAVID P	director, 10 percent owner, officer	President and CEO	M-Exempt	Buy	19,737	$3.55	$70.07K	1,048,197
Jan 04, 2024	LUCI DAVID P	director, 10 percent owner, officer	President and CEO	M-Exempt	Sell	19,737	$3.55	$70.07K	-
Jun 16, 2023	Donohue James J.	director	-	A-Award	Buy	10,000	$2.75	$27.50K	10,000
Jun 16, 2023	HARRISON THOMAS L	director	-	A-Award	Buy	10,000	$2.75	$27.50K	10,000
Jun 16, 2023	DEAN JACK H	director	-	A-Award	Buy	10,000	$2.75	$27.50K	10,000

The last insider sell of Acurx Pharmaceuticals's stock was made by Sailer Carl on Jan 22 2024, selling 19,737 shares at $3.55 per share (valued at $70.07K).

Acurx Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	5	-	-
Q1 2024	6	3	200.00%
Q4 2023	-	2	-
Q2 2023	5	-	-
Q1 2023	3	-	-
Q3 2022	5	-	-
Q4 2021	3	1	300.00%
Q3 2021	8	-	-
Q2 2021	4	8	50.00%
Q4 2019	-	1	-
Q3 2019	-	3	-
Q1 2019	-	1	-
Q4 2018	-	3	-
Q1 2018	-	5	-

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Acurx Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q3 2022	5	-	-
Q4 2021	3	-	-
Q3 2021	-	-	-
Q2 2021	1	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	-	-	-
Q1 2018	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Acurx Pharmaceuticals's stocks.

Acurx Pharmaceuticals Peer Ownership

Ticker	Company
ENOB	Renovaro Biosciences Inc.
PMVP	PMV Pharmaceuticals, Inc.
MNPR	Monopar Therapeutics Inc.
MLYS	Mineralys Therapeutics, Inc.
AVTE	Aerovate Therapeutics, Inc.
ACRV	Acrivon Therapeutics, Inc. Common Stock
ANTX	AN2 Therapeutics, Inc.
RZLT	Rezolute, Inc.
CADL	Candel Therapeutics, Inc.
SILO	Silo Pharma, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
ADAG	Adagene Inc.
LUMO	Lumos Pharma, Inc.

ACXP Ownership FAQ

Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals is owned by institutional shareholders (7.78%), insiders (14.80%), and public (77.41%). The largest institutional shareholder of Acurx Pharmaceuticals is VANGUARD GROUP INC (3.18% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Acurx Pharmaceuticals?

Acurx Pharmaceuticals's major institutional shareholders are VANGUARD GROUP INC, PROSPECT FINANCIAL SERVICES LLC, GEODE CAPITAL MANAGEMENT, LLC, LPL FINANCIAL LLC, and MORGAN STANLEY. The top five shareholders own together 6.46% of the company's share outstanding.

How many Acurx Pharmaceuticals shareholders are there?

As of Jun 2024, there are 25 institutional shareholders of Acurx Pharmaceuticals.

What percentage of Acurx Pharmaceuticals is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 491.69K shares of Acurx Pharmaceuticals, representing 3.18% of the company's total shares outstanding, valued at $1.11M (as of Jun 2024).

What percentage of Acurx Pharmaceuticals is owned by PROSPECT FINANCIAL SERVICES LLC?

As of Jun 2024, PROSPECT FINANCIAL SERVICES LLC holds 278.1K shares of Acurx Pharmaceuticals (ACXP), compromising 1.80% of the company, valued at $625.72K.

What percentage of Acurx Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Acurx Pharmaceuticals. The company owns 130.02K of the company's shares outstanding (worth $292.57K).